Click Continue if you consent to use all non-essential cookies or choose your own cookie settings.
DHI Phase 2 Annual Report - Year 3 (August 2021 to July 2022)
1st November 2022
1st November 2022
This Year 3 annual report sets out the significant impact made by DHI over the past 12 months with continued success to report evident, including 5 projects transferred to other organisations as ready to scale. DHI continues to respond to the unprecedented demands on health and care service partners and the imperative for accelerated innovation. DHI’s design led innovation approach and methodology continues to evolve, and is increasingly recognised by our partners as differentiating and effective. This has led and shaped a number of key initiatives at different stages of DHI’s innovation process model (Page 5 Fig. 4) including scoping of drug deaths prevention initiatives with the Scottish Government (SG) Digital Lifelines Programme, initiating and developing the transformation of frailty identification and management within Midlothian Health & Social Care Partnership and influencing next generation pharmaceutical delivery planning with Roche, one of the worlds largest Biotech companies. In addition to scoping activity, DHI continues to balance the project portfolio with over 14 projects managed this year. One major programme activated this year was the Rural Centre of Excellence for Digital Health and Care Innovation in the Moray Region, funded by UK Government. This initiative allows DHI to create more focussed opportunities for rural communities. In doing so this gives us the chance to broaden the innovation pipeline into the integrated care agenda - stretching the innovation model, with a greater focus on social care, data sharing and commercialisation. Launch of the Moray RCE was marked by an official visit from UK and Scottish Government representatives. Iain Stewart MP, Parliamentary Under Secretary of State for Scotland and Richard Lochhead Member of the Scottish Parliament.